News
GRDX
3.400
+7.94%
0.250
Weekly Report: what happened at GRDX last week (0803-0807)?
Weekly Report · 2d ago
Weekly Report: what happened at GRDX last week (0727-0731)?
Weekly Report · 08/03 10:28
Weekly Report: what happened at GRDX last week (0720-0724)?
Weekly Report · 07/27 10:33
GridAI Technologies Extends Secured Convertible Loan to Pronghorn
TipRanks · 07/23 20:42
Weekly Report: what happened at GRDX last week (0713-0717)?
Weekly Report · 07/20 10:29
Weekly Report: what happened at GRDX last week (0706-0710)?
Weekly Report · 07/13 10:31
GridAI Technologies Announces Private Equity Financing Agreement
TipRanks · 07/06 21:49
Weekly Report: what happened at GRDX last week (0629-0703)?
Weekly Report · 07/06 10:35
Weekly Report: what happened at GRDX last week (0622-0626)?
Weekly Report · 06/29 10:29
Weekly Report: what happened at GRDX last week (0615-0619)?
Weekly Report · 06/22 10:40
Weekly Report: what happened at GRDX last week (0608-0612)?
Weekly Report · 06/15 10:41
Weekly Report: what happened at GRDX last week (0601-0605)?
Weekly Report · 06/08 10:35
Weekly Report: what happened at GRDX last week (0525-0529)?
Weekly Report · 06/01 10:41
GridAI files to sell 6.2M shares of common stock for holders
TipRanks · 05/28 10:27
Weekly Report: what happened at GRDX last week (0518-0522)?
Weekly Report · 05/25 10:45
GridAI Announces Debt Settlement and Equity Conversion Agreement
TipRanks · 05/20 20:51
Weekly Report: what happened at GRDX last week (0511-0515)?
Weekly Report · 05/18 10:45
GridAI Technologies Delays Latest Quarterly Filing
TipRanks · 05/15 23:37
GridAI Technologies Announces New Private Equity Financings
TipRanks · 05/14 21:27
Weekly Report: what happened at GRDX last week (0504-0508)?
Weekly Report · 05/11 10:42
More
Webull provides a variety of real-time GRDX stock news. You can receive the latest news about GridAI Tech through multiple platforms. This information may help you make smarter investment decisions.
About GRDX
GridAI Technologies Corp., formerly Entero Therapeutics, Inc., offers a grid-edge, artificial intelligence (AI)-driven software and control platform that enables utilities, retail energy providers, and large power users to dynamically manage load and distributed energy resources, including battery energy storage systems. It applies real-time AI scheduling and optimization to orchestrate devices, fleets, and grid-scale assets. The Company also focuses on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company's programs address significant unmet needs in GI health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.